Testosterone Replacement Therapy in Men With Type 2 Diabetes Mellitus and Low Testosterone Levels

Trial Profile

Testosterone Replacement Therapy in Men With Type 2 Diabetes Mellitus and Low Testosterone Levels

Completed
Phase of Trial: Phase II/III

Latest Information Update: 30 Jun 2014

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Jun 2012 Planned end date changed from 1 Sep 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
    • 24 Jan 2009 Additional trial centre identified as reported by ClinicalTrials.gov, last updated 16-01-2009
    • 16 Jan 2009 Actual initiation date changed from May 2008 to Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top